The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

by Rätsep Indrek, Ravi Ramalingam R, Pachl Jan, Murillo-Cabezas Francisco, Mantilla Jorge, Hartzenberg Bennie, Frost Chris, Fletcher Olivia, Druwé Patrick, Dewan Yashbir, Quintero Juan, Boeriu Cristian, Balica Laura, Asser Toomas, Andrews Peter, Shakur Haleema, Sampaio Cristina, Singh Manmohan, Svoboda Petr, Roberts Ian
Published 2009-12-01